Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • glados
    Member
    • Mar 2012
    • 59

    Cufflinks parameters question

    Hello all.

    I am using the Tuxedo workflow and trying to figure out the best parameters to use for my data. It's not easy, there are many options to decide whether to include or not include, and for a beginner it can also be difficult understanding them all. In the protocol paper they did not include many parameters at all, but I am sure some of them are quite useful.

    My data is Illumina HiSeq 100bp paired end reads from a plant. I have a reference genome and annotation and have been assembling against the reference genome with the -gtf option in tophat. Mainly I want to focus on two conditions and test for differential expression between the two, but alternative splicing and novel splice sites, etc are also interesting.

    Can you comment on some of the Cufflinks parameters and voice your opinion if you think they are appropriate for me to include?

    So far I have been using Cufflinks mainly with these parameters:
    --GTF-guide
    --frag-bias-correct
    --upper-quartile-norm
    --multi-read-correct

    --frag-bias-correct and --multi-read-correct seems like appropriate choices to include, but what about the other two? I still do not fully understand the RABT assembly and what it does and it seems like there are several normalization options, which one should I choose? Additionally I wonder if I should use the same parameters in every step in the Cufflinks workflow or only in the initial Cufflinks run? For example, many parameters like --frag-bias-correct you can use both in Cufflinks and in Cuffdiff. Cuffmerge has both a --ref-gtf and a --ref-sequence option. Is it a good idea to include both in Cuffmerge?

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...